DK
Dakshidin Corporation
DKSC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $1.33M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
54 /100
Fair EV/EBITDA 9.83x
P/B 195.64x
P/E N/A
Growth
0 /100
Declining Book val. growth 63.68%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 11.51%
Asset turnover 0.00x
ROA 4.27%
Debt
39 /100
Moderate Debt/Equity 21.66x
Net debt/EBITDA 0.98x
Current ratio -0.00x
Stability
33 /100
Unstable Beta -0.51x
Profitable years 0
Rev. volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DKSC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christopher Robin Haigh
Employees
0
Headquarters
Miami